Bunzl PLC — M&A Activity 2025

Apr 30, 2025

National Storage Mechanism | Additional information

RNS Number : 6827G

Bunzl PLC

30 April 2025

30 April 2025

BUNZL ANNOUNCES ACQUISITIONS IN CHILE AND THE NETHERLANDS

Bunzl plc, the specialist international distribution and services Group, today announces that it has signed an agreement to acquire a business in Chile and has completed the acquisition of a business in the Netherlands.

Bunzl has entered into an agreement to acquire Hospitalia, one of the largest healthcare distributors in Chile. The business distributes a wide range of products, including those used in a surgical setting, to both public and private hospitals. This represents our entry into the healthcare sector in Chile, with the business generating revenue of CLP 25 billion (c.£21 million) in 2024. Completion of the acquisition is subject to competition authority clearance, which is expected in the next few months.

Bunzl has also completed the acquisition of Inpakomed, a Dutch business specialising in sterile product packaging solutions for use in the medical and forensic markets. The business is highly complementary to our existing business in the Netherlands and in 2024 generated revenue of EUR 3 million (c.£2 million).

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

"Bunzl is a highly cash generative business which allows us to prioritise investment in self-funded value-accretive acquisitions to drive growth, and our pipeline remains active. I am pleased to welcome the team from Hospitalia to Bunzl, with the acquisition marking our expansion into the attractive Chilean healthcare market, as well as the team from Inpakomed, who will expand our product and service offering to customers in the Netherlands."

Enquiries:

Bunzl plc   Frank van Zanten, Chief Executive Officer  Richard Howes, Chief Financial Officer  Sunita Entwisle, Head of Investor Relations and Communications  Tel: +44 (0)20 7725 5000	Teneo   Martin Robinson  Giles Kernick  Tel: +44 (0)20 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQILMATMTMTBAA